202 related articles for article (PubMed ID: 35817530)
21. An update to the pathogenesis for monoclonal gammopathy of renal significance.
Zuo C; Zhu Y; Xu G
Ann Hematol; 2020 Apr; 99(4):703-714. PubMed ID: 32103323
[TBL] [Abstract][Full Text] [Related]
22. Crystalglobulin-associated nephropathy presenting as MGRS in a case of monoclonal B-cell lymphocytosis: a case report.
Gupta RK; Arend LJ; Bk A; Narsipur S; Bhargava R
BMC Nephrol; 2020 May; 21(1):184. PubMed ID: 32423442
[TBL] [Abstract][Full Text] [Related]
23. Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.
Ali A; Schlanger L; Nasr SH; Sethi S; Gorbatkin SM
Am J Kidney Dis; 2016 Mar; 67(3):479-82. PubMed ID: 26704376
[TBL] [Abstract][Full Text] [Related]
24. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
Gomes-Alves I; Castro-Ferreira I
Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
[TBL] [Abstract][Full Text] [Related]
25. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.
Zand L; Kattah A; Fervenza FC; Smith RJ; Nasr SH; Zhang Y; Vrana JA; Leung N; Cornell LD; Sethi S
Am J Kidney Dis; 2013 Sep; 62(3):506-14. PubMed ID: 23623956
[TBL] [Abstract][Full Text] [Related]
26. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
[TBL] [Abstract][Full Text] [Related]
27. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Leung N; Bridoux F; Batuman V; Chaidos A; Cockwell P; D'Agati VD; Dispenzieri A; Fervenza FC; Fermand JP; Gibbs S; Gillmore JD; Herrera GA; Jaccard A; Jevremovic D; Kastritis E; Kukreti V; Kyle RA; Lachmann HJ; Larsen CP; Ludwig H; Markowitz GS; Merlini G; Mollee P; Picken MM; Rajkumar VS; Royal V; Sanders PW; Sethi S; Venner CP; Voorhees PM; Wechalekar AD; Weiss BM; Nasr SH
Nat Rev Nephrol; 2019 Jan; 15(1):45-59. PubMed ID: 30510265
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal gammopathy-associated proliferative glomerulonephritis.
Sethi S; Rajkumar SV
Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
[TBL] [Abstract][Full Text] [Related]
29. The ultrastructural basis of renal pathology in monoclonal gammopathies.
Santostefano M; Zanchelli F; Zaccaria A; Poletti G; Fusaroli M
J Nephrol; 2005; 18(6):659-75. PubMed ID: 16358223
[TBL] [Abstract][Full Text] [Related]
30. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
31. New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.
Kapoulas S; Raptis V; Papaioannou M
Nephrol Ther; 2015 Jun; 11(3):135-43. PubMed ID: 25861714
[TBL] [Abstract][Full Text] [Related]
32. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F
Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
[TBL] [Abstract][Full Text] [Related]
33. Light Chain-Only Immunotactoid Glomerulopathy: A Case Report.
Bu L; Javaugue V; Chauvet S; Napier J; Dasari S; Theis JD; Vrana JA; McPhail ED; Nasr SH
Am J Kidney Dis; 2023 May; 81(5):611-615. PubMed ID: 36328099
[TBL] [Abstract][Full Text] [Related]
34. Crystalline deposits in the cornea and various areas of the kidney as symptoms of an underlying monoclonal gammopathy: a case report.
Lindemann C; Enders P; Brinkkoetter PT; Völker LA
BMC Nephrol; 2021 Apr; 22(1):117. PubMed ID: 33823814
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.
He H; Wang Z; Xu J; Liu Y; Shao Y; Hou Y; Gu J; Hu R; Xing G
Sci Rep; 2024 Apr; 14(1):7667. PubMed ID: 38561447
[TBL] [Abstract][Full Text] [Related]
37. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
38. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
[TBL] [Abstract][Full Text] [Related]
39. [Classification and Management of MGRS Related Diseases].
Angioi A; Lepori N; Derudas D; Floris M; Mascia G; Cabiddu G; Pani A
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007837
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
